LEPTOMENINGEAL MYELOMATOSIS

This adverse event was reported 13 times

LEPTOMENINGEAL MYELOMATOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ALFUZOSIN HYDROCHLORIDE 2 0.0008
1 INOTUZUMAB OZOGAMICIN 2 0.0007
2 PIPERACILLIN AND TAZOBACTAM 2 0.0002
3 ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE 1 0.0001
4 CARFILZOMIB 4 0.0001
5 MESNA INJECTION 1 0.0001
6 MESNA 1 0.0001
7 PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM 2 0.0001
8 CYTARABINE 5 0.0001
9 PIPERACILLIN SODIUM,TAZOBACTAM SODIUM 2 0.0001
See all drugs enriched for association with LEPTOMENINGEAL MYELOMATOSIS